These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16054200)

  • 1. Pelvic sidewall adenocarcinoma after definitive therapy for cervical adenocarcinoma in situ.
    Miller B; Dunn J; Dalrymple J; Krivak TC
    Gynecol Oncol; 2005 Nov; 99(2):489-92. PubMed ID: 16054200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent invasive adenocarcinoma after hysterectomy for cervical adenocarcinoma in situ.
    Krivak TC; Retherford B; Voskuil S; Rose GS; Alagoz T
    Gynecol Oncol; 2000 May; 77(2):334-5. PubMed ID: 10785491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservative management of adenocarcinoma in situ of the cervix.
    Shin CH; Schorge JO; Lee KR; Sheets EE
    Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma in situ of the cervix: management and outcome.
    Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
    Denehy TR; Gregori CA; Breen JL
    Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
    DeSimone CP; Day ME; Dietrich CS; Tovar MM; Modesitt SC
    J Reprod Med; 2011; 56(9-10):376-80. PubMed ID: 22010519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
    Poynor EA; Barakat RR; Hoskins WJ
    Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenocarcinoma in situ of the uterine cervix.
    Muntz HG; Bell DA; Lage JM; Goff BA; Feldman S; Rice LW
    Obstet Gynecol; 1992 Dec; 80(6):935-9. PubMed ID: 1448263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenocarcinoma in situ of the uterine cervix: management and outcome.
    Widrich T; Kennedy AW; Myers TM; Hart WR; Wirth S
    Gynecol Oncol; 1996 Jun; 61(3):304-8. PubMed ID: 8641606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive adenocarcinoma of the cervix following LLETZ (large loop excision of the transformation zone) for adenocarcinoma in situ.
    Kennedy AW; elTabbakh GH; Biscotti CV; Wirth S
    Gynecol Oncol; 1995 Aug; 58(2):274-7. PubMed ID: 7622120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.
    Bull-Phelps SL; Garner EI; Walsh CS; Gehrig PA; Miller DS; Schorge JO
    Gynecol Oncol; 2007 Nov; 107(2):316-9. PubMed ID: 17689593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical adenocarcinoma in situ.
    Hopkins MP; Roberts JA; Schmidt RW
    Obstet Gynecol; 1988 Jun; 71(6 Pt 1):842-4. PubMed ID: 3285263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive cervical adenocarcinoma immediately following a cone biopsy for adenocarcinoma in situ with negative margins.
    Cohn DE; Morrison CD; Zanagnolo VL; Goist MM; Copeland LJ
    Gynecol Oncol; 2005 Jul; 98(1):158-60. PubMed ID: 15913738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
    Ostör AG; Duncan A; Quinn M; Rome R
    Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endocervical adenocarcinoma in situ. A histological entity to know].
    Fignon A; Mayelo V; Wurst C; Magnin G; Tariel D; Descamps P; Renjard L; Body G; Lansac J
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(4):369-73. PubMed ID: 7650312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postconization surveillance of cervical adenocarcinoma in situ. A prospective trial.
    Schorge JO; Lea JS; Ashfaq R
    J Reprod Med; 2003 Oct; 48(10):751-5. PubMed ID: 14619639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of loop electrosurgical excisional procedure in the management of adenocarcinoma in situ of the uterine cervix.
    Kim JH; Park JY; Kim DY; Kim YM; Kim YT; Nam JH
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):100-3. PubMed ID: 19428171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation of the mechanisms underlying the disparity between rate of residual endocervical adenocarcinoma in situ (AIS) in hysterectomy specimens and clinical failure rate following conservatively treated AIS.
    Goldstein NS
    Am J Clin Pathol; 2004 Oct; 122(4):540-5. PubMed ID: 15487451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Persistence and recurrence of in situ cervical adenocarcinoma after primary treatment. About 121 cases].
    Dedecker F; Graesslin O; Bonneau S; Quéreux C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):616-22. PubMed ID: 18539502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central pelvic recurrence 7 years after radical vaginal trachelectomy.
    Bali A; Weekes A; Van Trappen P; Jeyarajah A; Querleu D
    Gynecol Oncol; 2005 Mar; 96(3):854-6. PubMed ID: 15721437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.